<DOC>
	<DOC>NCT02480712</DOC>
	<brief_summary>This study will evaluate the antiviral efficacy, safety and tolerability of sofosbuvir (SOF)/velpatasvir (VEL; GS-5816) fixed dose combination (FDC) administered for 12 weeks in HCV treatment-naive and treatment-experienced (including treatment intolerant) adults with chronic HCV infection who are coinfected with HIV-1.</brief_summary>
	<brief_title>Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Coinfection</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>HCV RNA â‰¥ 10^4 IU/mL at screening HCV genotype 1, 2, 3, 4, 5, 6 Cirrhosis determination, a fibroscan or liver biopsy may be required HIV1 infection Use of protocol specified method(s) of contraception Screening laboratory values within defined thresholds Clinicallysignificant illness (other than HCV or HIV) or any other major medical disorder that may interfere with individual's treatment, assessment or compliance with the protocol Current or prior history of clinical hepatic decompensation, hepatocellular carcinoma (HCC) or other malignancy (with the exception of certain resolved skin cancers) Screening ECG with clinically significant abnormalities Pregnant or nursing female or male with pregnant female partner Infection with hepatitis B virus (HBV) Use of any prohibited concomitant medications as described in the protocol Chronic use of systemically administered immunosuppressive agents</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>